Filing Details

Accession Number:
0001140361-15-001488
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-01-12 18:39:54
Reporting Period:
2015-01-09
Filing Date:
2015-01-12
Accepted Time:
2015-01-12 18:39:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1379006 Nanoviricides Inc. NNVC Services-Commercial Physical & Biological Research (8731) 760674577
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1513285 Anil Diwan 135 Wood Street
West Haven CT 06516
President Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-01-09 4,000 $2.58 2,048,918 No 4 P Direct
Common Stock Acquisiton 2015-01-12 5,000 $2.57 2,053,918 No 4 P Direct
Common Stock Acquisiton 2015-01-12 5,000 $2.54 2,058,918 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. Includes 285,714 shares of common stock issuable upon exercise of options held by Dr. Diwan that are currently exercisable. Does not include 16,531,429 shares owned by TheraCour Pharma, Inc. (after calculating the Preferred Series A convertible as converted), over which Dr. Diwan holds voting and dispositive power. Does not include 500,000 shares of the Company's Series A Convertible Preferred Stock (the "Series A") which votes at the rate of nine shares of Common Stock per each share of Series A and is convertible into three and one half shares of Common Stock upon a change in control of the Company or upon achieving certain trading prices of the Common Stock (the "Series A Preferred Stock").